MINNEAPOLIS, May 14, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the market leading medical device company for BPH in-office procedures, announced scheduled participation in multiple events at the American Urological Association (AUA) 2012 Annual Meeting to be held at the Georgia World Congress Center in Atlanta from May 19th through May 23rd. The Company’s event participation is intended to sharpen the focus on advancements in the in-office treatment of BPH. Urologix offers early and effective treatment of obstructive and symptomatic urinary conditions due to benign prostatic hyperplasia (BPH) and provides urologists with two proven technologies to treat the widest range of patients, with Cooled ThermoTherapy™ and Prostiva® RF Therapy.
